Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Bayer, Corteva in 'two-dog battle' over U.S. soy market

Stock MarketsApr 09, 2021 07:50AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
2/2 © Reuters. FILE PHOTO: Soy leaves that were damaged by a weed killer in 2018 2/2

By Tom Polansek

CHICAGO (Reuters) - Bayer AG (DE:BAYGN) is launching a new genetically modified soybean in the United States, striking back against rival Corteva (NYSE:CTVA) Inc in a bid to retain its dominant position supplying seeds to the $40 billion U.S. soy industry.

Billions of dollars are on the table for companies producing a growing variety of seeds for soybeans, the top U.S. export crop, as farmers expand acreage this year due to soaring crop prices.

Bayer (OTC:BAYRY)'s new XtendFlex soybeans and Corteva's Enlist E3 soy are shaping up to be the most popular with farmers in the coming years, according to interviews with a dozen seed makers, dealers and farmers. Each seed tolerates three chemical herbicides so farmers can destroy weeds without damaging their crops, as weeds grow increasingly resistant to the once-universal glyphosate herbicide.

XtendFlex soybeans are marketed alongside the previous top U.S. soybean seed, Bayer's Xtend, but offer resistance to one additional weedkiller.

Bayer bought glyphosate-developer Monsanto (NYSE:MON) for $63 billion in 2018. The following year, Corteva challenged Monsanto's two-decade-long U.S. market dominance by launching Enlist on a small scale. For farmers, the competition is welcome after they had little choice but to accept Monsanto's seeds for years.

"It is setting up to be a two-dog battle between XtendFlex and Enlist," said Jim Herr, a manager for Beck's Hybrids, a seed company that sells Bayer and Corteva brands.

SEEDS OF CHANGE

Corteva, spun off in 2019 after a merger of Dow Chemical and Dupont, says Enlist will account for about 30% of U.S. soy plantings this year, or about 26 million acres. That is up from 20% in 2020, the first year they were widely available, according to the company.

Another player, BASF SE (OTC:BASFY), is distributing a new soybean brand, Xitavo, which contains Enlist technology. It will cover just a few hundred thousand acres in its first year, BASF said.

Enlist was the first soybean genetically modified to withstand sprays from two weed chemicals as well as glyphosate. Corteva expects it will eventually account for half of North America's soybean plantings, said Susanne Wasson, president of the company's crop protection business.

At Latham Hi-Tech Seeds, an Iowa-based company that sells seed to farmers across seven U.S. states, total soybean seed sales are up about 20% and Enlist is the most popular, President John Latham said.

Seed sellers said some farmers have been reluctant to try XtendFlex because they are unsure of how well it will produce crops.

Dealers could not sell the seeds to farmers last year because Bayer was awaiting approval for XtendFlex from soybean importers. The final clearance did not come until September from the European Union.

In February, Bayer estimated XtendFlex soybeans will account for at least 15 million acres this spring, or about 17% of plantings. That is down from the 20 million acres the company estimated last year, likely due to the delayed approval.

"People want to see it, feel it themselves, and that just wasn't possible this last year because of the late approval," Latham said.

XtendFlex soybeans resist a herbicide known as dicamba that tends to drift and damage vulnerable plants, along with the weedkillers glufosinate and glyphosate. The crop appeals to some farmers who do not want to spray dicamba because of the drifting risk, but want protection if neighbors spray it.

Illinois farmer Dan Henebry said he dumped plans to plant Enlist in favor of XtendFlex after the EU approval. He wants to use dicamba to kill weeds and prevent them from emerging from his soil. He said he will turn to glufosinate if he needs to fight weeds late in the summer.

For each crop season from 2021 to 2025, the Environmental Protection Agency (EPA) has banned farmers from using dicamba after June 30 because heat can increase the risk of drifting.

'NO. 1 SOYBEAN SYSTEM'

Bayer's Xtend soybeans resist dicamba and glyphosate only. The company said it expects to remain "the number one soybean system for weed control in North America" in 2021 with its Xtend and XtendFlex offerings.

Bayer declined to estimate Xtend soy plantings, which flatlined at about 50 million acres last year amid increased competition from Enlist soy.

Companies generally strike deals with farmers to produce crops for seeds ahead of the spring growing season based on expected demand. The companies then sell the seeds to other farmers to plant the following year.

Projecting demand for 2021 was trickier than usual, dealers said, after a U.S. appeals court in California in June blocked Bayer from selling dicamba, making Xtend soybeans less attractive.

Nebraska farmer Scott Langemeier said Corteva called him in August offering to buy the Enlist soybeans he was growing, anticipating a surge in seed demand for 2021 plantings after the dicamba court verdict. He had not planned to sell his crop for seed but agreed when Corteva offered a premium.

Then, the Trump administration's EPA in October approved dicamba use for five years, nullifying the court's decision and dealing a blow to Corteva in the seed battle.

"Now that dicamba went through, I think they're sitting on some beans that they didn't need," Langemeier said of Corteva.

Bayer, Corteva in 'two-dog battle' over U.S. soy market
 

Related Articles

3 Downgraded Stocks to Dump Now
3 Downgraded Stocks to Dump Now By StockNews - Jul 27, 2021

Despite the S&P 500's recent bounce, the market environment remains perilous. Participation in the advance is limited which explains the underperformance of small and mid-caps...

2 Biotech Stocks to Buy for Outsized Gains
2 Biotech Stocks to Buy for Outsized Gains By StockNews - Jul 27, 2021

Biotech companies have experienced exponential growth over the past year owing to their contribution to efforts to combat the COVID-19 pandemic. The rising demand for medicines and...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (1)
Benjamin McIntire
Benjamin McIntire Apr 09, 2021 8:20AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
So gross.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email